Our Cells Have A Danger Response
How stress locks your body in a loop of inflammation and fatigue
In Parts I through III of this series, we explored how the gut and mitochondria serve as the body’s communication hubs. We discussed how the microbiome influences metabolism, immunity, and even brain function. In this fourth and final installment, we delve one layer deeper into the language of stress itself: how chronic psychological, environmental, or metabolic stressors can cause our cells to become stuck in a state of danger, locking the body in a loop of inflammation and fatigue that underlies much of modern chronic disease.
Every cell is listening
Each cell in the human body is a living sensor, continually interpreting signals from its environment. It listens for shifts in nutrient availability, oxidative stress, and microbial or chemical threats.
When something feels ‘off,’ the cell doesn’t wait for instructions from the brain or immune system, it launches it’s own emergency protocol, a (theoretical) metabolic program known as the Cell Danger Response (CDR).
The CDR is not a disease state; it is the ancient survival reflex that halts normal activity of growth, repair, and communication so that cells can isolate, contain, and neutralize a threat. When this defensive program fails to resolve, however, the body becomes stuck in a perpetual state of ‘on.’ Healing can stall, energy can wane, and chronic symptoms can begin to emerge.
The concept of the Cell Danger Response (CDR) was first articulated by Dr. Robert Naviaux (UC San Diego) to describe a unifying model of how cells respond to threat. The framework integrates decades of research on mitochondrial signaling, metabolism, and immune activation, but the specific construct of the “CDR” as a named, sequential healing program remains a theoretical synthesis, not a formally validated medical model, and it serves as a useful framework for understanding chronic dysregulation.
How cells translate stress into survival
As explored in Article 3 of our series, our mitochondria act as biosensors and communication hubs. They interpret various forms of stress, ranging from physical to emotional, chemical, or microbial, and determine whether a cell should remain in growth or shift into defense. The types of stress mitochondria respond to are wide-ranging:
Biological stressors: chronic infections, viral reactivation, gut dysbiosis, and bacterial fragments such as lipopolysaccharides (LPS) that leak into circulation.
Chemical and environmental stressors: heavy metals, pesticides, air pollution, and mold toxins, impair mitochondrial enzymes and elevate oxidative stress.
Nutrient and metabolic stressors: insufficient cofactors (B vitamins, magnesium, CoQ10, amino acids) or overnutrition from refined foods that overwhelm redox balance.
Physical and psychological stressors: overexercise, trauma, sleep deprivation, and persistent emotional strain, all of which activate the same biochemical pathways as infection or injury.
Energetic overload: constant blue-light exposure, EMFs, and heat extremes that disrupt circadian signaling and mitochondrial communication.
In response, mitochondria shift from their most efficient oxygen-based metabolism, called oxidative phosphorylation (OXPHOS), to a faster but less efficient system known as glycolysis. Even when oxygen is available, stressed cells make this switch.
The purpose is about survival, as glycolysis allows a quick energy burst to fuel immune defenses and repair, but produces only a fraction of the energy that OXPHOS can generate. So when infection, toxins, or psychological stress are present, cells don’t need to make energy perfectly; they just need to make it fast enough to mount a defense. When glycolysis remains the cell’s primary source of energy creation, energy output remains low and unsustainable.
This change incurs additional costs, as OXPHOS slows and the production of reactive oxygen species (ROS) increases. While these molecules are often blamed for damage, at moderate levels, they serve as essential signals that activate genes that regulate inflammation and defense.
When the stress is short-lived, this response is life-saving, but if the triggers persist, ROS accumulate faster than antioxidant systems can neutralize them, creating a feedback loop of oxidative stress and inflammation.
When cellular alarms don’t switch off
As the mitochondria shift into defense, they release a series of biochemical alarms. Small fragments of mitochondrial DNA (mtDNA) leak into the cell and bloodstream through temporary membrane pores, functioning as damage-associated molecular patterns, serving as the cell’s internal fire alarm.
At the same time, energy production that is normally used for cell energy is released outside the cell. There, energy takes on a new role: a ‘danger signal’ that binds to purinergic receptors (notably P2X7) on immune cells, amplifying the inflammatory cascade.
For a brief time, this heightened state is protective and helps the body contain infection, remove toxins, and repair tissue. When the alarm remains active, the consequences spread far beyond the original threat. Repeated activation of these mitochondrial distress signals damages membranes, depletes antioxidants, and traps the cell in a loop of inflammation and energy depletion.
Clinically, this often looks like patients who struggle to recover: persistent fatigue, brain fog, low stress tolerance, or exercise intolerance despite normal lab results. The cellular machinery is functioning, but it is doing so under a standing order: “Stay alert, danger is still present!”
How cells rewire themselves under chronic stress
Prolonged activation of the CDR changes not just how cells make energy, but how they communicate and behave. This reprogramming resembles the Warburg effect, a metabolic pattern seen in both immune and cancer cells, where glucose is converted to lactate even when oxygen is abundant. This trade-off allows cells to prioritize defense over growth. They produce enough energy to survive but not enough to thrive.
Meanwhile, mitochondria and the cell nucleus fall out of sync. Normally, these two structures maintain an ongoing dialogue through small signaling peptides such as MOTS-c, which regulate gene expression and coordinate metabolic adjustments.
Under chronic stress, that dialogue weakens. Communication breakdowns mean that even when the external stressor has passed, the cell continues to behave as if it hasn’t. It remains metabolically rigid and unable to transition from survival back to regeneration.
Practitioners may recognize this pattern in clients who feel ‘stuck.’ Their bodies have adapted to long-term threat perception, and the cellular programs meant to help them survive are not preventing them from healing.
How our cells know it is safe to heal again
At the center of recovery lies a molecular switch known as NRF2. This is considered the body’s master regulator of antioxidant and detoxification pathways, and when oxidative stress rises from toxins, infection, or emotional strain, NRF2 moves into the nucleus and activates genes that create glutathione, antioxidant enzymes, and repair proteins.
It is, quite literally, the biochemical signal that it’s safe to rebuild. When NRF2 signaling is impaired from poor sleep, nutrient depletion, chronic inflammation, or toxic exposure, the cell remains locked in a defensive state. Energy continues to be spent on protection instead of regeneration.
Clinically, this manifests as individuals who struggle to bounce back, characterized by persistent fatigue, inflammatory reactivity, or slowed recovery despite doing ‘all the right things.’ Supporting NRF2 through phytonutrients (sulforaphane, curcumin, resveratrol), cruciferous vegetables, restorative sleep, rhythmic movement, and time in natural light helps re-engage this repair signal. These interventions are literal safety cues, reminding our body that a threat has passed, inviting the cell to return to balance.
When the body’s alarm won’t turn off
Another crucial component in the CDR is the NLRP3 inflammasome, an internal sensor that detects danger molecules released during stress. When energy, ROS, or mtDNA fragments accumulate, NLRP3 activates and releases inflammatory messengers (cytokines) such as interleukin-1β (IL-1β) and interleukin-18 (IL-18).
In acute phases, this system is beneficial because it calls immune cells to action and initiates repair. But chronic activation keeps the immune system in a low-grade state of alert. Over time, this sustained signaling contributes to autoimmunity, neuroinflammation, and metabolic dysfunction.
Interventions that reduce mitochondrial load, repair the gut barrier, optimize micronutrients, and manage psychosocial stress help quiet this inflammasome and re-establish immune tolerance. By restoring redox balance and improving mitochondrial communication, we allow the body to lower its defenses and begin repair.
How the body knows danger has passed
Inflammation is supposed to end. Once a threat is neutralized, the body must receive a clear biochemical signal that it’s safe to stand down. That signal comes from adenosine, which is produced when specialized enzymes (CD39 and CD73) break down energy outside the cell, and specialized compounds derived from Omega-3 (resolvins and protectins).
Together, these compounds actively promote tissue repair and signal the transition from defense to homeostasis. When adenosine binds to A2A receptors on immune and blood cells, it acts as a message of resolution, reducing chemical messaging from cytokines, improving circulation, and promoting tissue repair.
If this conversation process is impaired by the presence of toxins, chronic psychological stress, or disrupted metabolism, the ‘off switch’ for inflammation never fully engages. The body remains in defense, expending energy long after the threat has passed. The goal is not to suppress inflammation; it is to complete it, helping the body recognize that it is safe once again.
Clearing debris: how the body resets after defense
Once the alarms are quiet, the body needs to clean up the damage left behind. Autophagy, the process of recycling cellular components, and mitophagy, the targeted removal of damaged mitochondria, are essential for full recovery. When these pathways stagnate, dysfunctional organelles continue leaking ROS and mtDNA, perpetuating low-level inflammation.
Practices such as fasting, structured exercise, adequate sleep, and nutrient sufficiency gently reactivate these processes. Meanwhile, the gut-mitochondria-microbiome axis plays a crucial role in determining how effectively the body restores balance.
Dysbiosis or intestinal permeability allows bacterial fragments (like LPS) to enter circulation, keeping the mitochondria on alert. Restoring microbial diversity, strengthening the gut barrier, and replenishing mitochondrial cofactors (B vitamins, magnesium, CoQ10) help signal systemic safety. These are part of the same message: “It is time to rebuild.”
When healing requires a system reset
The CDR resolves only when cells collectively perceive safety. When energy release ceases, oxidative balance normalizes, and communication between mitochondria and the nucleus is restored. Recovery follows three guiding principles:
Reduce ongoing threats: remove infections, toxins, and chronic stressors
Support resolution: enhance NRF2 activity, adenosine signaling, and autophagy
Rebuild capacity: restore mitochondrial integrity, nutrient sufficiency, and microbial balance.
When these elements align, energy production returns to oxidative metabolism, inflammation resolves, and the system transitions from defense to regeneration.
Practitioner Takeaways
The Cell Danger Response represents a protective adaptation, not pathology. Chronic illness often reflects a CDR that was not completed.
Mitochondria integrate all forms of stress, including biological, chemical, and emotional, and translate them into energy and immune communication.
Common presentations: fatigue, brain fog, inflammatory sensitivity, “wired but tired” states, and slow recovery despite clean labs.
Key clinical levers:
Support NRF2 activation through phytonutrients and restorative lifestyle habits.
Reduce inflammasome activity by repairing gut integrity and balancing redox state.
Promote resolution through adenosine signaling (rest, parasympathetic activation, magnesium) and Omega-3 fatty acids, including EPA and DHA.
Reactivate autophagy and mitophagy with fasting, exercise, and circadian rhythm repair.
Rebuild microbial diversity to stabilize the gut-mitochondria axis.
Healing is ultimately about restoring the body’s perception of safety. Every nutritional, behavioral, or environmental intervention is a way of telling the cell: “The danger is over. You can begin again.”
For a deeper understanding
Gut health and chronic disease (Part I): Understanding the connection
Gut health and chronic disease (Part II): Our gut biome’s co-workers and their role in resilience
Gut health as a determinant of mitochondrial function
If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.
References
Agorastos A., & Chrousos G. P. (2022). The neuroendocrinology of stress: The stress-related continuum of chronic disease development. Molecular Psychiatry, 27, 502–513.
Ai, Y., Wang, H., Liu, L., Qi, Y., Tang, S., Tang, J., & Chen, N. (2023). Purine and purinergic receptors in health and disease. MedComm (2020), 4(5), e359 https://doi.org/10.1002/mco2.359
Guo, Y., Cho, S. W., Saxena, D., & Li, X. (2020). The multifaceted actions of succinate as a signalling transmitter vary with its cellular location. Endocrinology and Metabolism, 35(1),36–43. https://doi.org/10.3803/EnM.2020.35.1.36
Hough, D., Mao, A. R., Aman, M., Lozano, R., Smith-Hicks, C., Martinez-Cerdeno, V., Derby, M., Rome, Z., Malan, N., & Findling, R. L. (2023). Randomized clinical trial of low-dose suramin intravenous infusions for the treatment of autism spectrum disorder. Annals ofGeneral Psychiatry, 22(1),45.https://doi.org/10.1186/s12991-023-00477-8
Huang, Y., Zhou, J., Peng, X., & Liu, X. (2021). From purines to purinergic signalling: Molecular functions and human diseases. Signal Transduction and Targeted Therapy, 6(1),68.https://doi.org/10.1038/s41392-021-00553-z Naviaux, R. K. (2014a). Metabolic features of the cell danger response. Mitochondrion,16,7–17. https://doi.org/10.1016/j.mito.2013.08.006
Lu S., Wei F., & Li G. (2021). The evolution of the concept of stress and the framework of the stress system. Cell Stress, 5, 76–84.
Naviaux, R. K. (2020). Perspective: Cell danger response Biology—The new science that connects environmental health with mitochondria and the rising tide of chronic illness. Mitochondrion, 51,40–45. https://doi.org/10.1016/j.mito.2019.12.005
Naviaux, R. K., Curtis, B., Li, K., Naviaux, J. C., Bright, A. T., Reiner, G. E., Westerfield, M., Goh, S., Alaynick, W. A., Wang, L., Capparelli, E. V., Adams, C., Sun, J., Jain, S., He, F., Arellano, D. A., Mash, L. E., Chukoskie, L., Lincoln, A., & Townsend, J. (2017). Low-dose suramin in autism spectrum disorder: A small, phase I/II, randomized clinical trial. Annals of Clinical and Translational Neurology, 4(7),491–505. https://doi.org/10.1002/acn3.424
Naviaux, R. K., & Naviaux, J. C. (2017a). Antipurinergic therapy for autism: An in-depth review. Mitochondrion. https://doi.org/10.1016/j.mito.2017.12.007
Noushad S. et al. (2021). Physiological biomarkers of chronic stress: A systematic review. International Journal of Health Sciences, 15, 46–53.
Pizzorno J. E., & Murray M. T. (2020). Textbook of Natural Medicine (5th ed., Ch. 136). Elsevier.
Ruscio M. (2023). How to recognize & treat a cell danger response. Retrieved from https://drruscio.com/how-to-treat-cell-danger-response/
Steffan, D., Pezzini, C., Esposito, M., & Franco-Romero, A. (2025). Mitochondrial aging in the CNS: Unravelling implications for neurological health and disease. Biomolecules, 15(9), 1252. https://doi.org/10.3390/biom15091252
Territo, P. R., Ferraris, D., & Kirkwood, C. A. (2021). P2X7 receptors in neurodegeneration. Frontiers in Cellular Neuroscience, 15, Article617036. https://doi.org/10.3389/fncel.2021.617036
Wei, S., Song, X., Mou, Y., Zhou, W., Zhao, T., Li, W., Yang, H., & Chen, J. (2025). New insights into pathogenisis and therapies of P2X7R in Parkinson’s disease. Npj Parkinson's Disease, 11, 108. https://doi.org/10.1038/s41531-025-00980-7
Wu Z., Qu J., Zhang W., & Liu G.-H. (2024). Stress, epigenetics, and aging: Unraveling the intricate crosstalk. Molecular Cell, 84, 34–56.
Xu, X., Pang, Y., & Fan, X. (2025). Mitochondria in oxidative stress, inflammation and aging: From mechanisms to therapeutic advances. Signal Transduction and Targeted Therapy, 10,190. https://doi.org/10.1038/s41392-025-02253-4
Zong, Y., Li, H., Liao, P., Peng, Y., Yu, D., Wang, X., Hou, Y., Ma, C., Tian, M., Chen, T., Zhang, Y., Dong, C., Song, W., Wang, C., Li, C., Du, J., Wang, Q., Hu, S., Wang, T., Zhang, P., Ma, X., & Liu, G. (2024). Mitochondrial dysfunction: Mechanisms and advances in therapy. Signal Transduction and Targeted Therapy, 9, 124. https://doi.org/10.1038/s41392-024-01839-8
 | A guest post by
|